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Lutz Lüdemann3, Martin Stuschke3 and Verena Jendrossek1*Abstract
Background: Lymphocyte infiltration is a common feature of radiation-induced pneumonitis and fibrosis, but their
contribution to the pathogenic processes is still unclear. Here, we addressed the impact of thorax irradiation on the
T cell compartment with a focus on immunosuppressive regulatory T cells (Treg).
Methods: C57BL/6 wild type mice (WT) received anesthesia only (sham controls, 0 Gy) or were exposed to a single
dose of whole thorax irradiation (15 Gy). Immune cells from lung tissue, spleen, and cervical lymph nodes were
collected 10 to 84 days post-irradiation and phenotypically characterized by flow cytometry.
Results: Whole thorax irradiation provoked an increased influx of CD3+ T cells at 42 and 84 days post-irradiation. In
contrast, local irradiation caused a sustained reduction in CD3+ T cells in peripheral lymphoid tissues. Interestingly,
we observed a significant local and systemic increase in the fraction of CD4+ T cells expressing the transcription
factor forkhead box P3 (FoxP3), the phenotypic marker for murine Treg, at day 21 post-irradiation. The accumulation
of Treg was associated with increased levels of T cells expressing surface proteins characteristic for recruitment and
immunosuppressive activity, e.g. CD103, CTLA-4 and CD73. Importantly, Treg isolated at this time point were able to
suppress CD4+ effector T cells to a similar extent as Treg isolated from control mice.
Conclusions: The response of the adaptive immune system to whole thorax irradiation is characterized by local
immunoactivation and systemic immunosuppression. The transient accumulation of immunosuppressive CD4+
FoxP3+ Treg may be required to protect the lung against excessive inflammation-induced tissue damage. Further
investigations shall define the mechanisms underlying the accumulation of Treg and their role for the pathogenesis
of radiation-induced lung disease.
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Radiotherapy is an integral part of current standard
treatment concepts in oncology and provides a broad
contribution to cancer cure alone and in combined
treatment regimens. However, despite the high thera-
peutic potential of radiotherapy alone and in multimodal
combinations with surgery, chemotherapy, or targeted
drug therapy, a low tolerance of the normal tissue to* Correspondence: verena.jendrossek@uni-due.de
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article, unless otherwise stated.radiotherapy can considerably limit the success of radio-
therapy: Acute and late toxicity to normal tissues within
the irradiated volume not only decreases the quality
of life but also precludes the application of a curative
radiation dose to the tumor resulting in local relapse
particularly in tumors with high intrinsic radiation
resistance. Hence, researchers aim to improve the thera-
peutic ratio by technical and physical innovations in treat-
ment delivery, e.g. intensity-modulated radiation therapy
(IMRT) or particle therapy, as well as by developing effect-
ive biology-based strategies to prevent or treat the toxic
effects of ionizing radiation affecting normal tissues with-
out increasing radiation resistance of the tumor cells.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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highly radiosensitive tissue with little repair capacity. As
a consequence, radiation-induced pneumonitis and fi-
brosis are observed as severe dose-limiting complica-
tions of total body irradiation (TBI) or radiotherapy of
thorax-associated neoplasms [1-3]. However, so far there
is no available effective pharmacotherapy suited to spe-
cifically prevent or treat radiation-induced lung disease
in the clinical setting so that a symptomatic anti-
inflammatory therapy remains standard of care, though
its use is disputed [4].
Depending on the total radiation dose and the irradi-
ated volume, patients develop a toxic inflammation of
the lung parenchyma (pneumonitis) within 4 to 12 weeks
post-irradiation without or with subsequent lung fi-
brosis. Radiation-induced lung fibrosis is mostly ob-
served 6 to 24 months after radiotherapy and may
become chronic in patients with a large irradiated lung
volume [4]. Interestingly, experimental models using
whole thorax or hemithorax irradiation of fibrosis-
sensitive mice (C57BL/6) mimic human disease with
respect to the time course and major symptoms so
that they can be used to define the underlying mecha-
nisms as well as disease biomarkers [5-8].
Investigations in patient probes and animal models
demonstrate a complex response of the lung tissue with
multiple interactions between resident cells (alveolar epi-
thelial cells I and II, endothelial cells, fibroblasts), stro-
mal factors and infiltrating immune cells [9,10]. It is
assumed that radiation-induced pulmonary fibrosis may
originate from a disturbed balance between tissue in-
flammation and repair as it has been described for other
fibrotic diseases [11]. However, it is still controversial
whether cells from the innate and adaptive immune sys-
tem directly contribute to radiation-induced tissue dam-
age or only modulate disease progression.
In this regard there is evidence from preclinical and
clinical investigations that T cells constitute an import-
ant part of the immune cells infiltrating the lung tissue
upon irradiation of the thoracic region [6,12-15]. Even
more important, the presence of CD4+ T-lymphocytes
in the bronchioalveolar lavage fluid (BALF) of irradi-
ated breast or lung cancer patients correlated with a
pneumonitic reaction [13,15]. A radiation-induced in-
crease in T-lymphocytes in the lung tissue, particularly
CD4+ T-lymphocytes, during the pneumonitic phase was
confirmed in rodent models [7,16,17]. Of note, depletion
of CD4+ T cells during the pneumonitic phase decreased
radiation-induced lung fibrosis pointing to a contribution
of these cells to disease pathogenesis [16]. In contrast,
lung fibrosis upon whole thorax irradiation was aggra-
vated in recombination-activating gene 2 (RAG2)-deficient
mice; these mice lack mature T- and B-lymphocytes sug-
gesting that lymphocytes may also have beneficial effectsin radiation-induced lung disease [18]. Interestingly, in
further own investigations thorax irradiation triggered
the early appearance of two distinct types of T-helper
cells in C57BL/6 mice, namely interleukin 17 (IL-17)-ex-
pressing CD4+ T cells and CD4+ FoxP3+ T-lymphocytes
in the lung tissue [18]. The above data suggest a causal
link between the recruitment or local expansion of specific
T-lymphocyte populations and the course of radiation-
induced lung disease. In the present investigation we ad-
dressed the potency of ionizing radiation to induce local
and systemic changes in the T cell compartment with a
focus on regulatory T cells (Treg) using a C57BL/6-based
murine model. Treg specifically express the transcription
factor FoxP3 which activates genes that silence many ef-
fector T cell genes and suppress T cell proliferation and
activation in the periphery by secreting inhibitory cyto-
kines such as transforming growth factor beta1 (TGF-β1)
and IL-10 [19].
Here, we show that radiation-induced pneumonitis is as-
sociated with specific local and systemic time-dependent
changes in the T cell compartment. Importantly, whole
thorax irradiation (WTI) triggered the local and systemic
accumulation of CD4+ FoxP3+ Treg with immunosup-
pressive capacities during the early pneumonitic phase.
These immunosuppressive cells may be necessary to keep
in check effector T cells with tissue destructive activity,
such as TH1 cells or IL-17-expressing TH17 cells. An im-
proved understanding of the underlying mechanisms and
of the role of these regulatory cells during radiation-
induced pneumonitis may open novel routes to prevent or
treat radiation-induced pneumonitis and fibrosis.
Material and methods
Mouse strains
Eight-to-twelve weeks-old C57BL/6 wild-type mice (WT)
were enrolled in the study. All animals were bred and
housed under specific pathogen-free conditions in the
Laboratory Animal Facility of the University Hospital
Essen. Food consisting of a commercial laboratory ani-
mal diet and drinking water were provided ad libitum.
The animal facility and all protocols were approved by the
Universities Animal Protection Boards in conjunction with
the Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen (LANUV) according to the German
animal welfare regulations (AZ.8.87-51.04.20.09.333).
Experimental setup for whole thorax irradiation (WTI)
For whole thorax irradiation, groups of four mice were
irradiated in parallel. Animals were anesthetized with 2%
isoflurane, placed in holders and irradiated simultan-
eously with a single dose of 0 Gy (sham control) or 15
Gray (Gy) over their whole thorax. The radiation dose
was applied using a Cobalt-60 source (Phillips, Hamburg,
Germany). The irradiation was performed using a field
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58 cm. The field size was additionally reduced to
23.3 cm × 1.5 cm field size (full width half maximum)
using two Lipowitz metal absorber blocks (5.3 cm
thickness) at focus surface distance of 44 cm. The beam
collimation allowed for the irradiation of an axial
1.5 cm thick slice covering the lungs of 4 mice fixed in
parallel position at a time. The mouse lung position
within the dedicated mice holders were validated once
with a CT scan of the complete positioning setup.
Dosimetry was performed with a type 31016 pin point
“3D chamber” (0.016 cm3), a reference semiflex chamber
type 31003 (0.3 cm3) and an electrometer type UNIDOS
(PTW, Freiburg, Germany). Dose was applied with an
accuracy of 3% (+3% for the two mice with 3 cm dis-
tance to central beam axis, -3% for the two mice with
9 cm distance to central beam axis). The body dose out-
side the irradiation field was found 1.3% of the pre-
scribed dose. The Co-60 source provided a dose rate of
approximately 0.5 Gy/min at the target.Collection of bronchoalveolar lavage fluid (BALF)
To obtain BAL fluid (BALF), a horizontal incision was
made in the dissected tracheal tube. A syringe needle
was connected and fixed by two surgical knots and the
lungs were lavaged three times with 0.4 mL PBS. All
fluid collected from one mouse was pooled and 50 μL
were cytospun onto glass slides at 400 rpm/5 min with a
Shandon Cytospin 4 (Thermo Scientific, USA). Slides
were allowed to air dry for several minutes and were
then Giemsa-stained. Stainings were further analysed via
bright-field microscopy.Isolation of lymphocytes from spleen, cervical lymph
nodes and lungs
Mice were sacrificed at days 10, 21, 42, or 84 post-
irradiation and lung tissue, cervical lymph nodes and
spleen were collected for further analysis as follows:Isolation from spleen
Spleens were rinsed with an erythrocyte lysis buffer (con-
taining 0.15 M NH4Cl, 10 mM KHCO3, and 0.5 M
EDTA), meshed through a 70 μm cell strainer, passed
through a 30 μm cell strainer and washed with complete
medium (RPMI medium supplemented with 10% fetal calf
serum, Penicilline and Streptomycine).Isolation from cervical lymph nodes
Cervical lymph node cells (cLN) were disrupted with
two 23G needles in PBS containing 2 mM EDTA and
2% fetal calf serum or complete medium respectively,
and collected in complete medium for further analysis.Isolation from lungs
Lungs were cut into pieces and digested in 1 mg/mL Colla-
genase D and 10 μg/mL DNAse for 45 min at 37°C and the
cell suspension filtered (70 μm cell strainer) and subsequently
centrifuged by 1500 rpm for 6 min. Total lung cells (TLC)
were then rinsed with an erythrocyte lysis buffer (containing
0.15 M NH4Cl, 10 mM KHCO3, and 0.5 M EDTA), passed
through a 30 μm cell strainer and washed with complete
medium for subsequent phenotyping.
Phenotyping of leukocytes by flow cytometry
Lung cells were stained with anti-mouse CD45 Pacific
Blue (30-F11) for determination of leukocytes in the lung
tissue. Splenocytes, cLN cells, and lung cells were further
fluorochrome-labeled with anti-mouse CD3ε (145-2C11),
CD4 (RM4-5), CD8 (53-6.7), CD45R/B220 (RA3-6B2),
CD39 (24DMS1), CD73 (TY/11.8) and CD103 (M290).
Detection of FoxP3 and CTLA-4 was performed using the
FoxP3 staining kit from eBioscience (Frankfurt, Germany)
with anti-mouse FoxP3 (FJK-16 s) and anti-mouse CTLA-
4 (UC10-4B9), according to the manufacturer’s recommen-
dations. All antibodies used in this study, were obtained
from BD Biosciences (Heidelberg, Germany), BioLegend
(Fell, Germany) or eBioscience (Frankfurt, Germany).
RNA isolation, cDNA synthesis and RT-PCR analysis
For RNA isolation ex vivo isolated lung tissues were lysed
in RLT-buffer using an ULTRA-TURRAX® UTC (IKA,
Staufen, Germany). RNA was isolated using RNeasy Mini
kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s instruction. Total RNA (1 μg) was used for reverse
transcription (RT) with Superscript™-II reverse transcript-
ase (Qiagen) using oligo-dT primers according to the
manufacturer’s instructions. 0.5 μL of obtained cDNA was
used for PCR reaction as previously described [20]. Ana-






CD4+CD25hi Treg were separated from cLNs and spleen
of mice that received 0 Gy or 15 Gy whole thorax irradi-
ation using a FACSAria II cell sorter (BD Biosciences). As
responder T cells, CD4+ T cells were purified from spleens
of naive WT mice using the CD4+ T cell isolation kit II
(Miltenyi Biotec, Bergisch-Gladbach, Germany) and were
labeled with Carboxyfluorescein succinimidyl ester (CFSE)
(Invitrogen). CD4+ responder T cells (1 × 105) were either
cultured alone or co-cultured with CD4+CD25hi Treg (1 ×
105) for 4 days in the presence of 1 μg/mL anti-CD3 (2C11;
BD Biosciences). Irradiated splenocytes from naive C57BL/
6 mice served as antigen-presenting cells (APCs) (3 × 105).
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If not otherwise indicated, data were obtained from 2 –
3 independent experiments with at least 3 mice each.
Mean values were calculated and used for analysis of
standard deviation (SD) or standard error (SEM) and
statistical significance. Differences were assessed by 2-
way ANOVA followed by Bonferroni’s multiple compari-
son test. Data analysis was performed with Prism 5.0
software (GraphPad, La Jolla, CA). Statistical significance
was set at the level of p < 0.05.
Results
WTI induces time-dependent changes in the immune cell
composition of the lung tissue
In a first set of experiments we compared radiation-
induced local changes in immune cell composition
within the lung tissue during the pneumonitic phase. To
this end, we exposed C57BL/6 wild type mice to a single
dose of WTI with 0 Gy or 15 Gy. Using flow cytometry
we subsequently analyzed phenotypic markers of leuko-
cytes isolated from the lung tissue 10 to 84 days post-
irradiation. While the fraction of total leukocytes (CD45+
cells; gating strategy: Figure 1A) in the lung tissue was
comparable to sham controls until 21 days after WTI with
15 Gy, a significant increase of CD45+ cells in the lung
tissue was observed at 42 and 84 days post-irradiation
(Figure 1B). The fraction of B-lymphocytes (B220+ cells)
in the irradiated lung tissue also remained relatively
constant during the early pneumonitic phase, but a signifi-
cant increase in B220+ cells was detected at 84 days
post-irradiation (Figure 1C). Finally, we also observed a
pronounced increase in CD3+ T cells at 42 and 84 days
post-irradiation compared to sham controls. Interestingly,
the increase in CD3+ Tcells was paralleled by a comparable
increase in the amount of CD4+ T cells, whereas the levels
of CD8+ T cells in the lungs of irradiated mice and the
sham controls did not differ significantly (Figure 1D-F).
Analysis of cells present in the bronchioalveolar lavage
fluid (BALF) of irradiated mice and sham controls
corroborated the above findings of increased immune
cell infiltration into the irradiated lungs at 21 days
post-irradiation (Figure 1G).
WTI triggers distinct time-dependent changes in the T cell
compartment of peripheral lymphoid organs
Next we examined the potential of WTI to induce systemic
changes in the T cell compartment. To this end, we iso-
lated lymphocytes from spleen and cervical lymph nodes
(cLN) and analyzed the fraction of CD3+ T-lymphocytes,
CD4+ T-lymphocytes and CD8+ T-lymphocytes using flow
cytometry. As shown in Figure 2A and B, WTI led to a sig-
nificant reduction of CD3+ T cells particularly the cervical
lymph nodes (cLN) and less pronounced in the spleen of
irradiated mice as compared to sham controls. The earlydrop in CD3+ T cells at days 10 and 21 post-irradiation
involved reduction of both CD4+ and CD8+ T cells
(Figure 2C-F). However, while the loss of CD4+ T cells
was only transient and normal levels were reconstituted
within 42 days post-irradiation, the suppressive effect of
irradiation on CD8+ T cells was long-lasting and a sig-
nificant reduction in the fraction of CD8+ T cells was
still observed at 42 days post-irradiation, particularly in
the cervical lymph nodes (Figure 2C-F).
Thorax irradiation triggers a local and systemic
accumulation of CD4+ FoxP3+ T regulatory cells
Since our earlier investigations suggested the generation
of Treg in the lungs of mice exposed to hemithorax ir-
radiation [18], we next examined time-dependent local
and systemic changes in the amount of Treg in the lung
tissue and peripheral lymphoid organs of mice exposed
to WTI with 15 Gy. FoxP3 is considered as a reliable
phenotypic marker of Treg, at least in mice [21-23].
Therefore, we examined the fraction of CD4+ FoxP3+
T cells in lung tissue, cervical lymph nodes and spleen
until 84 days post-irradiation (gating strategy Figure 3A).
Interestingly, we observed a significant increase in the
levels of CD4+ FoxP3+ T cells in the lungs of mice ex-
posed to WTI compared to sham irradiated mice at
21 days post-irradiation. However this increase was only
transient and levels of CD4+ FoxP3+ T cells in the lung
tissue reached values of sham controls within 42 days
post-irradiation (Figure 3B). The accumulation of CD4+
FoxP3+ T cells at 21 days post-irradiation could be con-
firmed by RT-PCR mRNA analysis of FoxP3 expression
levels in total lung RNA isolated from control and whole
thorax irradiated animals (Figure 3C). Interestingly, a sig-
nificant accumulation of CD4+ FoxP3+ T cells at day 21
post-irradiation was also observed in the analysis of
lymphocytes from cervical lymph nodes and spleen of
irradiated mice. Similarly to what was observed in lung
tissues this effect was only transient, though a trend to
higher levels of CD4+ FoxP3+ T cells in the peripheral
lymphoid organs could be already observed at 10 days
post-irradiation (Figure 3D-E).
Treg isolated from irradiated mice have normal
immunosuppressive function
Our data indicated that WTI leads to a local and systemic
accumulation of CD4+ FoxP3+ T cells in the CD4+ T
cell compartment during the early pneumonitic phase
at 21 days post-irradiation. Next we aimed to explore
whether CD4+ FoxP3 + cells that accumulate in the lung
tissue at 21 days post-irradiation also express specific
surface molecules associated with immunosuppressive
activity of Treg, such as the adenosinergic ectoenzymes
CD39 and CD73 [24,25]. Therefore, we performed a de-
tailed analysis of the fraction of CD4+ T cells expressing
B C
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Figure 1 Whole thorax irradiation (WTI) induces time-dependent local changes in the T cell compartment of the lung tissue. C57BL/6
mice received 0 Gy or 15 Gy whole thorax irradiation. At specified time points cells were isolated from lung tissue and stained with antibodies
against distinct leukocyte populations as indicated. (A) Gating strategy for lung cells: Living total lung cells were gated and further characterized
by gating on CD45+ cells (leukocytes). All subpopulations were then gated on the CD45+ population. At different time points, cells were isolated
from lung tissue, stained with antibodies against (B) total leukocytes (CD45+), (C) B-lymphocytes (B220+), (D) T-lymphocytes (CD3+), (E) CD4+
T-helper cells (CD4+) and (F) CD8+ T cells (CD8+) and analyzed by flow cytometry. Timelines of the indicated cell populations are shown with
mean values ± SEM of percentages calculated on total lung cells (TLC). Cells of 6-9 mice per group were analyzed, ** p≤ 0.01; *** p≤ 0.001, two-way
ANOVA followed by post-hoc Bonferroni test. (G) BALF (bronchoalveolar lavage fluid) was collected at 21 days post-irradiation from lungs of C57BL/6
mice irradiated with 15 Gy (right panel) and sham controls (left panel). Cytospin of BALF probes were stained with Giemsa and analyzed via
bright-field microscopy: left panel: BALF from a sham control; right panel BALF from a lung irradiated with 15 Gy (40 ×magnification). Pictures
show one representative slide.
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of sham controls. While levels of CD39+ CD4+ cells
remained mostly unaffected (Figure 4A) we observed an
increase in CD73+ CD4+ T cells in the lungs of mice ex-
posed to WTI as compared to sham controls (Figure 4B).
The time course of the increased surface expression of
CD73 on CD4+ T cells followed the time course observed
for the accumulation of CD4+ FoxP3+ T cells in the irradi-
ated mice with a maximum at 21 days post-irradiation.
Moreover, we noted a transient increase in CD4+ T cells
and CD4+ FoxP3+ Treg expressing the marker proteinsCTLA-4 (Figures 4C and 5A) and CD103, respectively
(Figures 4D and 5B), indicative for increased recruitment
and activation of these cells into the lung tissue [21,26].
Finally we explored whether Treg from irradiated mice
are functional and exert suppressive activity. For this we
used CD4+ CD25hi cells since sorting of viable Treg via
the intracellular marker FoxP3 (fixation step) is impos-
sible. Indeed, when comparing the phenotype and inhibi-
tory capacity of CD4+ CD25hi cells isolated by FACS
sorting from peripheral lymphoid organs of mice ex-
posed to WTI and sham controls at 21 days post-











































































































































Figure 2 WTI triggers distinct time-dependent changes in the T cell compartment of peripheral lymphoid organs. C57BL/6 mice received
0 Gy or 15 Gy whole thorax irradiation. At different time points, cells were isolated from cervical lymph nodes (cLN) and spleen (TSC) and stained with
antibodies against (A/B) CD3+ T cells (cLN and spleen), (C/D) CD4+ T-helper cells (cLN and spleen), (E/F) CD8+ T cells (cLN and spleen) as indicated.
Cells were analyzed by flow cytometry and timelines of the indicated cell populations are shown with mean values ± SEM of percentages calculated
on lymph node cells (LNC) or total spleen cells (TSC). Cells of 6-9 mice per group were analyzed, * p≤ 0.05; ** p≤ 0.01; *** p≤ 0.001, two-way ANOVA
followed by post-hoc Bonferroni test.
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expressed FoxP3 and could thus be considered as func-
tional Treg (Figure 5C). Importantly, CD4+ CD25hi Treg
isolated from cervical lymph nodes (Figure 5D left panel)
or spleen (Figure 5D right panel) of mice exposed to
WTI (black bars) were able to suppress proliferation of
untreated CD4+ T responder cells with similar potency
as CD4+ CD25hi Treg from sham controls (white bars).
These results indicate that WTI triggers accumulation of
Treg and that irradiation in vivo does not affect their im-
munosuppressive capacity.
Discussion
Exposure of the thoracic region to ionizing radiation
triggers time-dependent leukocyte infiltration into the
lung, including lymphocytes. We show here that irradi-
ation of the thoracic region exerts dual effects on the
adaptive immune system: While WTI caused a sustained
reduction in CD3+ T cells in peripheral lymphoid tissues
it provoked an increased recruitment of CD4+ T cells to
the lung tissue at 6 and 12 weeks post-irradiation. Im-
portantly, we demonstrate that radiation-induced local
immunoactivation was associated with local and sys-
temic accumulation of cells with the phenotype of im-
munosuppressive Treg. This assumption is based on thefollowing findings: i) WTI triggered a transient increase
in the CD4+ FoxP3+ cell fraction in the lungs and the
peripheral lymphoid organs of mice compared to sham
controls with a maximum at 21 days post-irradiation; ii)
at the time of increased FoxP3-expression the levels of
CD73, CD103 and of CTLA4 on CD4+ T cells were also
increased; iii) FoxP3+ expressing CD4+ CD25hi cells iso-
lated from irradiated mice displayed enhanced expres-
sion of the marker proteins CTLA-4 and CD103 and
exhibited unrestrained immunosuppressive activity.
In more detail, local irradiation of the thoracic region
caused a sustained systemic suppression of CD3+ T cells
in peripheral lymphoid organs that was characterized by
a transient decrease in CD4+ T cells and a long-lasting
reduction of CD8+ T cell numbers. These observations
suggest a more pronounced sensitivity of CD8+ T cells
to the cytotoxic action of IR in vivo compared to CD4+
T cells. Pronounced cytotoxic effects of local irradiation
on the circulating lymphocyte pool had already been ob-
served by others and had been attributed to blood flow
through the radiation field [27]. In contrast, after an ini-
tial slight decrease of lymphocyte numbers in the lung
tissue we observed increased levels of CD3+ T cells in
the lung tissue at 42 and 84 days post-irradiation, pre-



























































0 Gy 15 Gy
































Figure 3 WTI triggers a local and systemic accumulation of FoxP3+ T regulatory cells. C57BL/6 mice received 0 Gy or 15 Gy whole thorax
irradiation. At indicated time points, immune cells were isolated from lung tissue, spleen and cervical lymph nodes (cLN) and stained for flow cytometric
analysis. (A) Gating strategy for the detection of FoxP3 on CD4+ T cells. (B) Treg (CD4+ FoxP3+) cells change in the lung during pneumopathy. Mean
values ± SEM of the expression of FoxP3 are shown as percentages from CD4+ lung cells. (C) RT-PCR mRNA analysis of FoxP3 expression levels of total
lung RNA isolates derived from control as well as whole thorax irradiated animals 21 days after irradiation. βActin was included as control. Two images
per condition are shown. (D/E) Timelines of FoxP3 on gated CD4+ T cells in the cLN (D) and spleen (E) during pneumopathy. Shown are mean values ±
SEM of percentages calculated on CD4+ LNC and TSC. Cells of 6-9 mice/group were analyzed; ** p≤ 0.01, *** p≤ 0.001, two-way ANOVA followed by
post-hoc Bonferroni test.
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radiation-induced pneumonitis defined by maximum im-
pairment of lung function in our earlier investigations
[6,28]. Our present data corroborate earlier findings
from rodent models of thorax irradiation showing that
lymphocyte numbers increase after an initial early deple-
tion by 3 to 6 weeks post-irradiation [7,17].
It is known from preclinical and clinical investigations
that CD4+ and CD8+ T-lymphocytes constitute a signifi-
cant part of the immune cell infiltrate in the lung tissue
of irradiated breast and lung cancer patients with a pre-
dominance of the CD4+ subset [12-16]. Of note, the in-
crease in numbers of activated CD4+ T-lymphocytes in
the BALF is more pronounced in symptomatic patients
than in asymptomatic patients [13,15]. Vice-versa, in-
creased apoptosis of peripheral blood lymphocytes, par-
ticularly CD8+ T cells, after curative radiation therapy is
associated with reduced late toxicity [29]. In line with these
findings, depletion of CD4+ T cells during pneumonitisdecreased radiation-induced lung fibrosis in preclinical
investigations in rats [16]. These findings indicate that
infiltration of CD4+ T cells is a common feature of
radiation-induced pneumonitis and that these cells may
play a role for disease progression. Thus, CD4+ T cells
may be promising targets for the modulation of
radiation-induced late effects in the lung. However, so
far little was known about the phenotype and function
of CD4+ T-lymphocytes recruited to the lung tissue in
response to thoracic irradiation. This is of particular
interest because these cells depending on the microenvir-
onment can differentiate into diverse subsets with oppos-
ing pro-inflammatory or immunosuppressive function,
e.g. TH1, TH2 or TH17 cells and Treg, respectively.
Here we demonstrate for the first time that WTI leads
to a selective accumulation of CD4+ FoxP3+ T cells both
in lungs and peripheral lymphoid organs of mice at 21 days
post-irradiation. These findings corroborate our recent
observation about the appearance of CD4+ FoxP3+
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Figure 4 WTI-induced changes in the T cell phenotype are associated with altered surface expression of immunoregulatory molecules
on CD4+ T cells. C57BL/6 mice received 0 Gy or 15 Gy whole thorax irradiation. At different time points, immune cells were isolated from lung
tissue and stained for flow cytometric analysis. (A) Expression of CD39 on gated CD4+ T cells in the lung. (B) Expression of CD73 on gated CD4+
T cells in the lung. (C) Detection of CTLA-4 expression on gated CD4+ T cells in the lung. (D) Expression of CD103 on gated CD4+ T cells in the
lung. Timelines of the indicated cell populations are shown as mean values ± SEM of percentages calculated on total lung cells. Cells of 4-6 mice
per group were analyzed, * p≤ 0.05; *** p≤ 0.001, two-way ANOVA followed by post-hoc Bonferroni test.
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hemithorax irradiation [18]. However, it had not yet been
shown that local irradiation of the thoracic region also
triggers a time-dependent accumulation of CD4+ FoxP3+
T-lymphocytes in cervical lymph nodes and in the spleen.
The observation that local thorax irradiation also affects
the T cell compartment in peripheral lymphoid organs
supports earlier findings about systemic effects of a local
irradiation: In this regard, irradiation of prostate tumors
grown on the hint-leg of C57BL/6 mice resulted in the ac-
cumulation of CD4+CD25hi FoxP3+ lymphocytes in per-
ipheral lymphoid organs [30]. Moreover, others and we
have shown that lymphocyte infiltration after thorax ir-
radiation is not exclusively confined to the radiation field
but can also be observed in non-irradiated parts of the
lung further corroborating a systemic response of the im-
mune system to local irradiation [6,12,13,31].
Since thorax irradiation led to a decrease in CD3+ T
cells by tendency at 21 days post-irradiation, it may be
speculated that the radiation-induced accumulation of
Treg during the pneumonitic phase may at least partially
be due to increased survival of Treg compared to T ef-
fector lymphocytes. Such enhanced resistance of CD4+
FoxP3+ cells and of CD4+ CD25hi FoxP3+ cells toionizing radiation compared to other T-lymphocytes has
recently been reported in vitro and in vivo in different
experimental models [30,32-36] and had been attributed
among others to enhanced expression of anti-apoptotic
Bcl-2 and therefore increased resistance to apoptosis
[32,33]. However, T-lymphocytes are generally character-
ized by a high intrinsic sensitivity to ionizing radiation
so that only a minor population will survive WTI with
15 Gy. Certainly, thorax irradiation is known to pro-
voke an increase in the levels of TGF-β1 [37], a cyto-
kine involved in the differentiation of Treg [38-40].
Thus, radiation-induced changes in the lung micro-
environment may alternatively trigger a local expansion
of CD4+ FoxP3+ T-lymphocytes recruited to the lung
tissue.
Of note, our data also demonstrate that Treg isolated
from the lymphoid tissues of irradiated mice are fully
functionally active: The CD4+ FoxP3 T cell fraction dis-
played up-regulated expression of surface molecules asso-
ciated with recruitment and immunosuppressive function,
namely CD103 and CTLA-4 [26,41,42]. In this scenario,
up-regulation of CD103 on both, CD4+ T cells and CD4+
FoxP3+ suggests that Treg originate from CD4+ T cells
newly recruited to the lung tissue whereas up-regulation





























































































Figure 5 Treg isolated from irradiated mice have normal immunosuppressive function. C57BL/6 mice received 0 Gy or 15 Gy whole thorax
irradiation. At different time points, immune cells were isolated from lung tissue and stained for flow cytometric analysis. (A) Detection of CTLA-4
on CD4+ FoxP3+ Treg in the lung. (B) Expression of CD103 on CD4+ FoxP3+ Treg in the lung. Timelines are shown as mean values ± SEM of
percentages calculated on total lung cells. Cells of 4-6 mice per group were analyzed (* p≤ 0.05; ** p≤ 0.01; two-way ANOVA followed by
post-hoc Bonferroni test). (C) Gating strategy for FACS-sorting of Treg from cervical lymph nodes and spleen. CD4+ CD25hi cells are 92% FoxP3+.
Shown are dotplots from one representative experiment. (D) To determine the suppressive capability of regulatory T cells in vitro CD4+ CD25hi
T cells (Treg) from cervical lymph nodes and spleens of 0 Gy or 15 Gy whole thorax irradiated mice were isolated at 21 days post-irradiation by
FACS sorting. Treg were co-cultured at a ratio of 1:1 with CFSE-labeled CD4+ responder T cells and with antigen-presenting cells in the presence
of αCD3. Proliferation of responder T cells was measured by loss of the fluorescent dye CFSE and inhibition was calculated accordingly. Data from
three individual hosts are shown with mean values ± SEM.
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suppressive activity of the CD4+ FoxP3+ Treg via extracel-
lular generation of adenosine from adenine nucleotides
[24,25,43]. Our observation may provide an explanation
for the suggested role of adenosine as an important medi-
ator of tissue protection from radiation-induced injury
[44,45]. Finally, the CD4+ FoxP3+ T cells isolated from
irradiated mice exhibited a pronounced suppression of
T effector cell proliferation that was comparable to the
suppression exhibited by Treg isolated from cervical
lymph nodes and spleen of sham controls.
Up to now only sparse data are available about the
radiation-induced accumulation of Treg and contradictory
data have been published regarding their function in the
regulation of local and systemic responses to ionizing radi-
ation. Consistent with our findings, numbers of lympho-
cyte subsets in peripheral blood, lymph nodes, spleens
and thymuses of C57BL/6 mice decreased 2 weeks afterexposure to TBI with 5 Gy, whereas the fractions of
CD4+ CD25hi and CD4+ CD25hi FoxP3+ T cells in the
CD4+ T cell compartment increased [32]. Though CD4+
CD25hi Treg turned out to be functional, the authors
claimed a reduced immunosuppressive activity compared
to Treg isolated from non-irradiated mice. Similarly, the
fraction of CD4+ FoxP3+ T cells within the proliferating
CD4+ T cell pool increased in response to TBI with 2 Gy
but these cells displayed a reduced capacity to suppress
T effector cell proliferation [33]. In line with these
in vivo observations, human Treg isolated from the
peripheral blood of healthy donors displayed a dose-
dependent reduction in proliferation and immunosup-
pressive capacity upon in vitro irradiation compared to
non-irradiated controls [46]. In contrast, though local ir-
radiation of the legs of C57BL/6 mice bearing subcutane-
ous tumors also led to a rapid and transient increase of
CD4+ FoxP3+ and CD4+CD25hi FoxP3+ T cells in the
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http://www.ro-journal.com/content/9/1/98lung and peripheral lymphoid organs, functional activity
of these CD4+ FoxP3+ cells exposed to ionizing radiation
in vivo was not affected in this experimental setting which
is consistent with our present findings [30]. Altogether,
these data indicate that transient local and systemic accu-
mulation of CD4+ FoxP3+ Treg seems to constitute a
common immune response to irradiation in vivo, though
the kinetics and the functional state may depend on the
radiation dose and the target tissue, respectively.
In general, Treg induced in the periphery may be con-
sidered as readout for the initiation of cytotoxic effector
T cell responses known to play a key role in the main-
tenance of immune homeostasis and the suppression of
pro-inflammatory reactions [19,47]. We therefore specu-
late that accumulation of Treg upon local irradiation con-
tributes to the control of radiation-induced pneumonitis.
Functional Treg may be required to keep in check effector
cells of the innate and adaptive immune system, e.g. TH1,
TH17 cells, thereby limiting inflammation-associated tissue
damage and balancing tissue homeostasis [18,48-50].
However, when considering to target Treg for modulating
the outcome of radiation-induced normal tissue toxicity it
has to be taken into account that CD4+ FoxP3+ Treg may
have a distinct contribution for shaping the immune re-
sponse during the pneumonitic phase, which has many
characteristics of acute inflammation, and the fibrotic
phase characterized by chronic inflammation and tissue
repair with excessive deposition of extracellular matrix
and remodeling of the lung architecture, respectively
[51]. In this regard, Treg dampened lung inflammation
in a model of silica-induced lung disease, whereas depletion
of this cell population attenuated lung fibrosis through
maintenance of a TH1-dominated pro-inflammatory state
[52]. We assume that the action of Treg in the context of
radiation-induced lung disease may be similarly complex
and requires further definition.
Conclusion
Whole thorax irradiation exerts a dual effect on the
adaptive immune system characterised by local immu-
noactivation and systemic immunosuppression. More-
over, local irradiation of the thoracic region led to a
local and systemic expansion of immunosuppressive
CD4+ FoxP3+ cells during the early pneumonitic phase.
We speculate that these cells are needed to restrain the
local cytotoxic effector T cell response induced in the
lung in response to ionizing radiation thereby limiting
excessive inflammation-associated lung damage and re-
establishing tissue homeostasis. Further investigations
shall identify the origin of these cells and the mecha-
nisms governing their local and systemic accumulation.
Moreover, the identification of the role of Treg during
radiation-induced pneumonitis and fibrosis is required if
we aim to exploit radiation-induced immune changesfor developing effective strategies to prevent or treat
radiation-induced adverse effects in the lung.
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